Scaling Manufacturing of Novel Therapies

Key Takeaways

• Transitioning therapies from R&D to commercialization requires optimizing manufacturing processes to enhance yields while maintaining quality and regulatory compliance.
• Advanced technologies and innovative approaches are crucial for efficient large-scale production of new therapies.
• Collaboration among researchers, manufacturers, and regulatory bodies is essential to navigate the complexities of therapy commercialization.